EVP & COO Todd Nelson reflects on Porton J-STAR's defining milestones, global network strategy, and what’s ahead as the ...

ProBio has opened its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell ...

Vetter, a global Contract Development and Manufacturing Organization (CDMO), has begun construction of its new clinical ...

Bristol Myers Squibb (BMS) received U.S. Food and Drug Administration (FDA) approval for label updates for its CAR T cell ...

Incyte Board of Directors has unanimously appointed Bill Meury as President and Chief Executive Officer (CEO) and a member of ...

As the pharmaceutical industry continues to evolve, so too does the role of secondary packaging. From serialization and ...

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred the upstream phase of the manufacturing process for LUMEVOQ, its gene ...

AGC Biologics will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama ...

MAIA Biotechnology Inc., a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer ...

Silo Pharma Inc. has entered into a non-binding letter of intent to form a strategic 50:50 joint venture with Hoth ...

Bio-Thera Solutions and SteinCares have signed a new agreement to commercialize a proposed biosimilar of dupilumab across ...

Precision BioSciences, Inc. received a Rare Pediatric Disease Designation from the U.S. Food and Drug Administration (FDA) for PBGENE-DMD to treat Duchenne muscular dystrophy (DMD).